{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:38:44Z","timestamp":1792093124888,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.yebeh.2021.108057","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T21:16:54Z","timestamp":1622150214000},"page":"108057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"PA","title":["Seizures among young adults consuming kratom beverages in Malaysia: A case series"],"prefix":"10.1016","volume":"121","author":[{"given":"Sanihah Abdul","family":"Halim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen Hou","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Chuan","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamad Ridzuan","family":"Alias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.108057_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/SAR.S164261","article-title":"Current perspectives on the impact of Kratom use","volume":"10","author":"Veltri","year":"2019","journal-title":"Subst Abuse Rehabil"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108057_b0010","doi-asserted-by":"crossref","first-page":"e2582","DOI":"10.1002\/hup.2582","article-title":"Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia","volume":"32","author":"Singh","year":"2017","journal-title":"Hum Psychopharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108057_b0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/02791072.2015.1012610","article-title":"Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia","volume":"47","author":"Singh","year":"2015","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.yebeh.2021.108057_b0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","article-title":"The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse","volume":"134","author":"Kruegel","year":"2018","journal-title":"Neuropharmacol"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108057_b0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1212\/CPJ.0000000000000846","article-title":"Breakthrough seizure associated with kratom use in patients with epilepsy","volume":"11","author":"Burke","year":"2021","journal-title":"Neurol Clin Pract."},{"issue":"4","key":"10.1016\/j.yebeh.2021.108057_b0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13181-016-0588-y","article-title":"Suspected adulteration of commercial kratom products with 7-hydroxymitragynine","volume":"12","author":"Lydecker","year":"2016","journal-title":"J Med Toxicol"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108057_b0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ajem.2017.07.051","article-title":"Clinical outcomes after Kratom exposures: A poison center case series","volume":"36","author":"Cumpston","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"10","key":"10.1016\/j.yebeh.2021.108057_b0040","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/15563650.2019.1569236","article-title":"Kratom exposures reported to United States poison control centers: 2011\u20132017","volume":"57","author":"Post","year":"2019","journal-title":"Clin Toxicol."},{"key":"10.1016\/j.yebeh.2021.108057_b0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebcr.2018.04.002","article-title":"Recurrent seizures from chronic kratom use, an atypical herbal opioid","volume":"10","author":"Tatum","year":"2018","journal-title":"Epilepsy Behav Case Rep."},{"key":"10.1016\/j.yebeh.2021.108057_b0050","doi-asserted-by":"crossref","unstructured":"Afzal H, Esang M, Rahman S. A Case of Kratom-induced Seizures. Cureus. 2020 Jan 7;12(1): e6588. doi: 10.7759\/cureus.6588.","DOI":"10.7759\/cureus.6588"},{"issue":"4","key":"10.1016\/j.yebeh.2021.108057_b0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s13181-010-0079-5","article-title":"Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure","volume":"6","author":"Nelsen","year":"2010","journal-title":"J Med Toxicol"},{"issue":"6","key":"10.1016\/j.yebeh.2021.108057_b0060","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.yebeh.2021.108057_b0065","first-page":"65","article-title":"Brain magnetic resonance imaging of regular kratom (Mitragyna speciosa Korth.) users: a preliminary study","volume":"14","author":"Singh","year":"2018","journal-title":"Malaysian J Med Health Sci"},{"key":"10.1016\/j.yebeh.2021.108057_b0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"14","key":"10.1016\/j.yebeh.2021.108057_b0075","doi-asserted-by":"crossref","first-page":"326","DOI":"10.15585\/mmwr.mm6814a2","article-title":"Notes from the field: unintentional drug overdose deaths with kratom detected \u2013 27 states, july 2016-december 2017","volume":"68","author":"Olsen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.yebeh.2021.108057_b0080","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/0269881119862530","article-title":"Characteristics of deaths associated with kratom use","volume":"33","author":"Corkery","year":"2019","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.1016\/j.yebeh.2021.108057_b0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/02791072.2013.844532","article-title":"Kratom abuse in Ramathibodi Poison Center, Thailand: a five-year experience","volume":"45","author":"Trakulsrichai","year":"2013","journal-title":"J Psychoact Drugs"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108057_b0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1471-4159.2008.05361.x","article-title":"Cocaine-like neurochemical effects of antihistaminic medications","volume":"106","author":"Tanda","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2021.108057_b0095","doi-asserted-by":"crossref","unstructured":"Keary CJ, Wang Y, Moran JR, Zayas LV, Stern TA. Toxicologic testing for opiates: understanding false-positive and false-negative test results.Prim Care Companion CNS Disord. 2012;14(4): PCC.12f01371. doi: 10.4088\/PCC.12f01371.","DOI":"10.4088\/PCC.12f01371"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108057_b0100","article-title":"The effects of chronic mitragynine (Kratom) exposure on the EEG in rats","volume":"745","author":"Suhaimi","year":"2021","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108057_b0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00213-017-4813-4","article-title":"The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research","volume":"235","author":"Henningfield","year":"2018","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.yebeh.2021.108057_b0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0028-3908(92)90072-W","article-title":"Yohimbine-induced seizures involve NMDA and GABAergic transmission","volume":"31","author":"Dunn","year":"1992","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.yebeh.2021.108057_b0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0269881120914223","article-title":"Acute mitragynine administration suppresses cortical oscillatory power and systems theta coherence in rats","volume":"34","author":"Th\u00e9riault","year":"2020","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108057_b0120","first-page":"355","article-title":"Posterior reversible leukoencephalopathy syndrome after kratom ingestion","volume":"30","author":"Castillo","year":"2017","journal-title":"Proc (Bayl Univ Med Cent)."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021002912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021002912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:41:23Z","timestamp":1761504083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021002912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":24,"alternative-id":["S1525505021002912"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108057","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizures among young adults consuming kratom beverages in Malaysia: A case series","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108057"}}